MyAverix Finance
SHE · Healthcare
Wuhan Hvsen Biotechnology Co Ltd (300871)
Biotechnology
Wuhan Hvsen Biotechnology Co Ltd (300871) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $4.82B, P/E ratio is 20.19, net margin is 12.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300871
Wuhan Hvsen Biotechnology Co Ltd (300871) — FAQ
What is Wuhan Hvsen Biotechnology Co Ltd's market cap?
Wuhan Hvsen Biotechnology Co Ltd (300871) has a reported market cap of $4.82B (data as of 2026-03-28).
What is 300871's P/E ratio?
The price-to-earnings (P/E) ratio for Wuhan Hvsen Biotechnology Co Ltd (300871) is 20.19 (data as of 2026-03-28).
Does Wuhan Hvsen Biotechnology Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Wuhan Hvsen Biotechnology Co Ltd (300871). Check the MyAverix Finance app for the latest dividend data.
What sector is Wuhan Hvsen Biotechnology Co Ltd in?
Wuhan Hvsen Biotechnology Co Ltd (300871) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 300871 listed on?
300871 is listed on SHE.
What is Wuhan Hvsen Biotechnology Co Ltd's net margin?
Wuhan Hvsen Biotechnology Co Ltd (300871) reports a net margin of 12.9% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.